Comparative accuracy of cardiovascular risk prediction methods in primary care patients
Open Access
- 1 January 2001
- Vol. 85 (1) , 37-43
- https://doi.org/10.1136/heart.85.1.37
Abstract
OBJECTIVE To compare the relative accuracy of cardiovascular disease risk prediction methods based on equations derived from the Framingham heart study. DESIGN Risk factor data were collected prospectively from subjects being evaluated by their primary care physicians for prevention of cardiovascular disease. Projected cardiovascular risks were calculated for each patient with the Framingham equations, and also estimated from the risk tables and charts based on the same equations. SETTING 12 primary care practices (46 doctors) in Birmingham. PATIENTS 691 subjects aged 30–70 years. MAIN OUTCOME MEASURES Sensitivity, specificity, and positive and negative predictive values of the Framingham based risk tables and charts for treatment thresholds based on projected cardiovascular disease or coronary heart disease risk. RESULTS 59 subjects (8.5%) had projected 10 year coronary heart disease risks ⩾ 30%, and 291 (42.1%) had risks ⩾ 15%. At equivalent projected risk levels (10 year coronary heart disease ⩾ 30% and five year cardiovascular disease ⩾ 20%), the original Sheffield tables and those from New Zealand have the same sensitivities (40.0%, 95% confidence interval (CI) 26.6% to 57.8% v 41.2%, 95% CI 28.7% to 57.3%) and specificities (98.6%, 95% CI 97.2% to 99.3%v 99.7%, 95% CI 98.8% to 100%). Modifications to the Sheffield tables improve sensitivity (91.4%, 95% CI 81.3% to 96.9%) but reduce specificity (95.8%, 95% CI 93.9% to 97.3%). The revised joint British recommendations' charts have high specificity (98.7%, 95% CI 97.5% to 99.5%) and good sensitivity (84.7%, 95% CI 71.0% to 93.0%). CONCLUSIONS The revised joint British recommendations charts appear to have the best combination of sensitivity and specificity for use in primary care patients.Keywords
This publication has 19 references indexed in Scilit:
- Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey populationBMJ, 2000
- Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methodsBMJ, 2000
- Updated New Zealand cardiovascular disease risk-benefit prediction guideBMJ, 2000
- "Absolute" is inappropriate for quantitative risk estimationBMJ, 2000
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2Atherosclerosis, 1998
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Lipid-Lowering for Prevention of Coronary Heart Disease: What Policy Now?Clinical Science, 1996
- Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableThe Lancet, 1996
- Guidelines for managing raised blood pressureBMJ, 1996
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991